FASL Antikörper
Kurzübersicht für FASL Antikörper (ABIN2478844)
Target
Alle FASL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma." in: British journal of haematology, Vol. 166, Issue 5, pp. 690-701, (2014) (PubMed).
: "Natural killer cells in allergic rhinitis patients and nonatopic controls." in: International archives of allergy and immunology, Vol. 153, Issue 3, pp. 234-8, (2010) (PubMed).
: "Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment." in: Molecular and cellular biology, Vol. 25, Issue 15, pp. 6811-20, (2005) (PubMed).
-
: "Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma." in: British journal of haematology, Vol. 166, Issue 5, pp. 690-701, (2014) (PubMed).
-
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
-
Andere Bezeichnung
- CD178
-
Hintergrund
- Synonyms: FAS LIGAND
-
Gen-ID
- 356
-
UniProt
- P48023
-
Pathways
- Apoptose, EGFR Signaling Pathway, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
Target
-